Want to join the conversation?
$GRPN 2Q15 Call: In EMEA, billings were $434MM, with growth slightly accelerating from 7% in 1Q15 to 9% in 2Q15. Revenue grew 9% to $204MM. Local billings improved from a decline of 2% in 1Q15 to a growth of 4%. Segment operating income was $10MM, down $10MM versus 1Q15, driven by a decline in gross profit due in part to lower margins in goods.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?